Eculizumab for pregnancy-related atypical hemolytic uremic syndrome

Nephrol Dial Transplant. 2024 Sep 27;39(10):1731-1733. doi: 10.1093/ndt/gfae068.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Atypical Hemolytic Uremic Syndrome* / drug therapy
  • Complement Inactivating Agents / therapeutic use
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications* / drug therapy

Substances

  • eculizumab
  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents